Baldwin, Colleagues Call on Purdue Pharma to Cancel $1.3 Million Bonus for CEO
"By maintaining the aggressive incentive plan for Mr. Landau, the Board is showing that it does not recognize the role the incentive program played in accelerating the opioid crisis into a national tragedy."
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin led 10 of her Senate colleagues in sending a letter to Purdue Pharma’s Board of Directors, calling on them to cancel the reported $1.3 million bonus they are planning to give to Purdue Pharma CEO Craig Landau. Attorneys General from 24 states, including Wisconsin, have argued that Landau should not collect a bonus, and on Thursday, a bankruptcy judge is expected to issue a decision on whether the CEO can collect it.
From the letter, the Senators write,“We write to you today with concerns about the $1.3 million incentive bonus payment you have proposed to make to Purdue chief executive officer Craig Landau while your company is in Chapter 11 bankruptcy. Mr. Landau is a named defendant in multiple lawsuits, which allege he personally designed Purdue’s intentionally deceptive opioid marketing campaign. Further, the payment is based on aggressive performance incentives similar to those used to encourage opioid sales. As such, we ask that you cancel the incentive payment to Mr. Landau and reevaluate your incentive payment plan to ensure your company puts patient safety ahead of profits.”
The Senators continue,“By maintaining the aggressive incentive plan for Mr. Landau, the Board is showing that it does not recognize the role the incentive program played in accelerating the opioid crisis into a national tragedy. While the filings indicate that Purdue’s sales incentive plan will not pay bonuses for opioid sales, it is not clear that the operating profit incentive will exclude opioid sales from its calculation.”
The company’s recently-submitted compensation proposal would incentivize Mr. Landau to meet aggressive sales targets, and could result in the unwarranted prescription and irresponsible distribution of opioids and other addictive drugs. While the proposal indicates that Purdue’s sales incentive plan will not pay bonuses for opioid sales, it is not clear that the operating profit incentive will exclude opioid sales from its calculation. In their letter, the Senators highlight that there is no indication the very compensation policies that encouraged its employees to allegedly deceive doctors and patients to sell opioids have been removed from the current compensation plan to sell other drugs.
They conclude,“In closing, we again urge you to cancel your proposed incentive bonus payment to Mr. Landau, and reevaluate your entire incentive pay program to ensure that your company puts patient safety ahead of profits.”
The full letter is available here. An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
More about the Opioid Crisis
- County Executive Crowley, Chairwoman Nicholson Sign Legislation Approving $9 Million for Efforts to Compat the Opioid Crisis - County Executive David Crowley - Aug 15th, 2025
- How Are State’s Local Governments Spending Opioid Settlement Payouts? - Addie Costello - Aug 4th, 2025
- MKE County: How County Will Spend $9 Million in Drug Settlement Funds - Graham Kilmer - Jul 29th, 2025
- Milwaukee County Executive David Crowley Announces Over $9 Million for Initiatives to Combat Opioid Epidemic - County Executive David Crowley - Jul 17th, 2025
- AG Kaul, 45 Other Attorneys General Plan to Join $720 Million Settlement with Eight Opioid Drug Makers - Wisconsin Department of Justice - Jul 14th, 2025
- Attorney General Kaul Announces Consent Judgment with Kroger Over Opioid Crisis - Wisconsin Department of Justice - Mar 21st, 2025
- Baldwin Votes to Strengthen Penalties, Step Up Enforcement Around Deadly Fentanyl - U.S. Sen. Tammy Baldwin - Mar 17th, 2025
- Wisconsin Communities Get Millions From Opioid Settlement as Deaths Decline - Evan Casey - Mar 1st, 2025
- MKE County: County Creates Easy Public Access To Overdose Data - Graham Kilmer - Feb 18th, 2025
- Milwaukee County Executive David Crowley and the Office of Emergency Management Launch New Overdose Dashboard - County Executive David Crowley - Feb 18th, 2025
Read more about Opioid Crisis here
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Senator Baldwin Introduces Bill to Provide Healthcare For All Troops
Aug 21st, 2025 by U.S. Sen. Tammy BaldwinRoughly 130,000 men and women in the National Guard and Reserve do not have health insurance
Baldwin Presses Ascension on Decision to Outsource Staffing of Intensive Care Units to Private Equity-Backed Firm
Aug 15th, 2025 by U.S. Sen. Tammy BaldwinTeamHealth, a private equity-backed firm, has history of business practices that compromise patient care and safety
Baldwin, Moore, Steil Call for Trump Administration to Provide Immediate Federal Support for Flood Damage in Southeastern Wisconsin
Aug 14th, 2025 by U.S. Sen. Tammy BaldwinLawmakers support Wisconsin’s request for assistance with federal damage assessment